Health Condition 1: B850- Pediculosis due to Pediculus humanus capitis
Conditions
Interventions
Intervention1: Amrutveni LiceQit oil: Type of Product:
Herbal topical formulation (cosmeceutical / therapeutic oil)
Dosage Form:
Oil (for external application on scalp and hair)
Route of Administrat
Sponsors
Sahyadri Bio Labs Pvt. Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Individuals aged between 18 and 60 years Presence of head Lice infestation
Exclusion criteria
Exclusion criteria: Known hypersensitivity or allergy to any ingredients present in the Amrutveni LiceQit Oil. Presence of underlying dermatological scalp disorders such as psoriasis, seborrheic dermatitis, or eczema. Use of other anti-lice treatments or pediculicides within the preceding 7 days. Participation in any other clinical test within the past 30 days. Pregnant or lactating women, due to unknown effects on maternal or neonatal health.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean percentage reduction in live lice and nit count from baseline (Day 0) to Day 28, determined by standardized lice detection combing and count comparisonTimepoint: Day 0 (baseline), Day 1–7, Day 14, Day 21, and Day 28 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Change in Pediculosis Severity Score (PSS) from Day 0 to Day 28. 2. Change in itching intensity (VAS, 0–10). 3. Change in scalp inflammation/redness (0–3 scale). 4. Improvement in hair texture, softness, and manageability. 5. Change in hair volume and tangle score. 6. Overall subject satisfaction (1–5 Likert scale). 7. Incidence of local irritation, erythema, allergic reaction, and overall safety (IGDES score). Timepoint: Day 0 (baseline), Day 1–7, Day 14, Day 21, and Day 28 | — |
Countries
India
Contacts
Public ContactDr Kasthuri Nair A
Pankajakasthuri Ayurveda Medical college and PG centre
Outcome results
None listed